[Prostanorm in the treatment of chronic non-infectious prostatitis].
OBJECTIVE
To try efficacy of prostanorm against chronic non-infectious prostatitis (CNIP).


METHODS
Forty two 25 to 48 year old patients with CNIP received prostanorm treatment: 2 tablets, 3 times a day 30 min before meal or 40 min after meal for 6 weeks.


RESULTS
Prostanorm relieved symptoms significantly and improved quality of life, reduced prostatic size, increased maximal volumic speed of urine flow according to uroflowmetry.


CONCLUSIONS
Prostanorm is an effective and safe drug for treatment of patients with CNIP.
Mazo
E B
EB
Popov
S V
SV
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D018849:Controlled Clinical Trials as Topic; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009929:Organ Size / Q000187:drug effects; D028321:Plant Preparations / Q000627:therapeutic use*; D011472:Prostatitis / Q000188:drug therapy*; D011788:Quality of Life; D013607:Tablets; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D028321:Plant Preparations; D013607:Tablets